Status:
UNKNOWN
Impact of the Covid-19 on RSV
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Rhinovirus
RSV Infection
Eligibility:
All Genders
Up to 1 years
Brief Summary
The magnitude of seasonal RSV epidemics brings each year new logistical challenges for the hospitalization of young infants with bronchiolitis that overwhelm hospital capacities and lead to specific w...
Eligibility Criteria
Inclusion
- Child hospitalized at " Hôpital Femme Mère Enfant ", Lyon, France
- Positive RSV-PCR
Exclusion
- • Parent's refusal to participate
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05348616
Start Date
May 1 2022
End Date
July 1 2025
Last Update
May 3 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Virology Lab
Lyon, France, 69004
2
Pediatric departement
Lyon, France, 69500